132 related articles for article (PubMed ID: 28935466)
1. Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells.
Cascione M; De Matteis V; Toma CC; Pellegrino P; Leporatti S; Rinaldi R
Exp Cell Res; 2017 Nov; 360(2):303-309. PubMed ID: 28935466
[TBL] [Abstract][Full Text] [Related]
2. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration.
Ortíz-López L; Morales-Mulia S; Ramírez-Rodríguez G; Benítez-King G
J Pineal Res; 2009 Jan; 46(1):15-21. PubMed ID: 18482340
[TBL] [Abstract][Full Text] [Related]
3. ROCK Inhibitor Y-27632 Promotes Human Retinal Pigment Epithelium Survival by Altering Cellular Biomechanical Properties.
Ni Y; Qin Y; Fang Z; Zhang Z
Curr Mol Med; 2017; 17(9):637-646. PubMed ID: 29546834
[TBL] [Abstract][Full Text] [Related]
4. Softening of the actin cytoskeleton by inhibition of myosin II.
Martens JC; Radmacher M
Pflugers Arch; 2008 Apr; 456(1):95-100. PubMed ID: 18231808
[TBL] [Abstract][Full Text] [Related]
5. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration.
Schram K; Ganguly R; No EK; Fang X; Thong FS; Sweeney G
Endocrinology; 2011 May; 152(5):2037-47. PubMed ID: 21385940
[TBL] [Abstract][Full Text] [Related]
6. Interaction between mDia1 and ROCK in Rho-induced migration and adhesion of human dental pulp cells.
Cheng L; Xu J; Qian YY; Pan HY; Yang H; Shao MY; Cheng R; Hu T
Int Endod J; 2017 Jan; 50(1):15-23. PubMed ID: 26609804
[TBL] [Abstract][Full Text] [Related]
7. ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma.
Wang ZM; Yang DS; Liu J; Liu HB; Ye M; Zhang YF
Tumour Biol; 2016 Mar; 37(3):3757-64. PubMed ID: 26468018
[TBL] [Abstract][Full Text] [Related]
8. Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase.
Wilhelm KR; Roan E; Ghosh MC; Parthasarathi K; Waters CM
FEBS J; 2014 Feb; 281(3):957-69. PubMed ID: 24289040
[TBL] [Abstract][Full Text] [Related]
9. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells.
Bhandary L; Whipple RA; Vitolo MI; Charpentier MS; Boggs AE; Chakrabarti KR; Thompson KN; Martin SS
Oncotarget; 2015 Mar; 6(8):6251-66. PubMed ID: 25749040
[TBL] [Abstract][Full Text] [Related]
10. A Rho-associated coiled-coil containing kinases (ROCK) inhibitor, Y-27632, enhances adhesion, viability and differentiation of human term placenta-derived trophoblasts in vitro.
Motomura K; Okada N; Morita H; Hara M; Tamari M; Orimo K; Matsuda G; Imadome KI; Matsuda A; Nagamatsu T; Fujieda M; Sago H; Saito H; Matsumoto K
PLoS One; 2017; 12(5):e0177994. PubMed ID: 28542501
[TBL] [Abstract][Full Text] [Related]
11. AFM indentation study of breast cancer cells.
Li QS; Lee GY; Ong CN; Lim CT
Biochem Biophys Res Commun; 2008 Oct; 374(4):609-13. PubMed ID: 18656442
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.
Leonel C; Ferreira LC; Borin TF; Moschetta MG; Freitas GS; Haddad MR; de Camargos Pinto Robles JA; Aparecida Pires de Campos Zuccari D
Anticancer Agents Med Chem; 2017; 17(8):1113-1125. PubMed ID: 28042775
[TBL] [Abstract][Full Text] [Related]
13. Age related changes in cell stiffness of tendon stem/progenitor cells and a rejuvenating effect of ROCK-inhibition.
Kiderlen S; Polzer C; Rädler JO; Docheva D; Clausen-Schaumann H; Sudhop S
Biochem Biophys Res Commun; 2019 Feb; 509(3):839-844. PubMed ID: 30638929
[TBL] [Abstract][Full Text] [Related]
14. The role of RhoA kinase inhibition in human placenta-derived multipotent cells on neural phenotype and cell survival.
Wang CH; Wu CC; Hsu SH; Liou JY; Li YW; Wu KK; Lai YK; Yen BL
Biomaterials; 2013 Apr; 34(13):3223-30. PubMed ID: 23410680
[TBL] [Abstract][Full Text] [Related]
15. ROCK inhibitor Y-27632 maintains the proliferation of confluent human mesenchymal stem cells.
Nakamura K; Yoshimura A; Kaneko T; Sato K; Hara Y
J Periodontal Res; 2014 Jun; 49(3):363-70. PubMed ID: 23834550
[TBL] [Abstract][Full Text] [Related]
16. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
17. Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.
Borin TF; Arbab AS; Gelaleti GB; Ferreira LC; Moschetta MG; Jardim-Perassi BV; Iskander AS; Varma NR; Shankar A; Coimbra VB; Fabri VA; de Oliveira JG; Zuccari DA
J Pineal Res; 2016 Jan; 60(1):3-15. PubMed ID: 26292662
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol-Induced Temporal Variation in the Mechanical Properties of MCF-7 Breast Cancer Cells Investigated by Atomic Force Microscopy.
Iturri J; Weber A; Moreno-Cencerrado A; Vivanco MD; Benítez R; Leporatti S; Toca-Herrera JL
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277289
[TBL] [Abstract][Full Text] [Related]
19. Post-Passage rock inhibition induces cytoskeletal aberrations and apoptosis in Human embryonic stem cells.
Gao L; Nath SC; Jiao X; Zhou R; Nishikawa S; Krawetz R; Li X; Rancourt DE
Stem Cell Res; 2019 Dec; 41():101641. PubMed ID: 31710913
[TBL] [Abstract][Full Text] [Related]
20. Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells.
Wang L; Xue L; Yan H; Li J; Lu Y
Mol Biol Rep; 2010 Apr; 37(4):1971-7. PubMed ID: 19649725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]